Info
Insider Ownership

Insider Trading & Ownership of Charles Evan Ballantyne

Location: Hopkinton, MA
Summary: The estimated net worth of Charles Evan Ballantyne is at least $711,000 dollars as of 12 Apr 2023. Charles Evan Ballantyne is the Chief Financial Officer of Gain Therapeutics, Inc. and owns shares of Gain Therapeutics, Inc. (GANX) stock worth about $711,000.
Signature: /s/ Cathy Rude, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Charles Evan Ballantyne files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Charles Evan Ballantyne

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
GANX	Gain Therapeutics, Inc.	Chief Financial Officer	$711,000			10 Apr 2023

Insider Transactions Reported by Charles Evan Ballantyne:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.